COVID-19 and the vaccine development process: A closer look
By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing…
Issues of Stigma When Addressing Schizophrenia & Mental Illness
By: William Obilisundar, PharmD Candidate c/o 2023, Binghamton University School of Pharmacy and Pharmaceutical Sciences One of the most…
When Epidemic Meets Pandemic: Treatment of Opioid Use Disorder Amidst Coronavirus Disease 2019 (COVID-19)
By: Preethi Samuel, PharmD Candidate c/o 2021, Aisa Mrkulic, PharmD. Candidate c/o 2022 Opioid use disorder (OUD) is a…
Usage of Ibuprofen and Angiotensin-Converting Enzyme Inhibitors (ACEi) in Coronavirus 2019 (COVID-19) Patients: Should They Be Used?
By: Evan Cheung, PharmD (c/o 2020) On March 11th, 2020, a research article was published in the Lancet journal…
Dexamethasone and COVID-19
By: Natalia Loomis, PharmD Candidate c/o 2022 The World Health Organization announced the official name “COVID-19” on February 11, 2020…
NIH COVID-19 Treatment Guidelines Update: remdesivir, chloroquine, hydroxychloroquine, and azithromycin
By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome 2 (Sars-Cov-2), the viral strain responsible for causing COVID-19,…
Brexanolone (Zulresso™) in the treatment of Postpartum Depression
By: Shivani Kaneria, Pharm D. Candidate c/o 2020 Postpartum depression is a mood disorder that affects 10 – 20 percent…
All Hearts Matter!
By: Aiśa Mrkulic, PharmD. Candidate c/o 2022 APhA’s Red Dress Gala continues to be their largest, not-for-profit fundraising event of…
#MentalHealthMatters
By: Aiśa Mrkulic, PharmD. Candidate c/o 2022 Thrive NYC’s Adult Mental Health First Aid Training Program has taken Johnnies by…
Suffering from migraines? Eptinezumab-jjmr (Vyepti™) might be the answer
By: Alisha Kuriakose, PharmD Candidate c/o 2022 Every ten seconds, someone in the United States (U.S.) goes to the emergency…